ASH 2023 | High-risk myeloma

MPE Webinar ASH 2023 myeloma and AL amyloidosis highlightsПодробнее

Replay the #IMFASH23 Support Group Leader Discussion from ASH 2023Подробнее

Top Myeloma Research at ASH 2023 from a Patient PerspectiveПодробнее

Pre-diagnosis Dietary Patterns of Multiple Myeloma | Richa Parikh, MD | ASH 2023Подробнее

ASH 2023 Myeloma Recap with Dr. Ben DermanПодробнее

Results from the Optimum/Muknine Trial | Martin Kaiser, MD, FRCP, FRCPath | ASH 2023Подробнее

Serum Biomarkers and Progression Risk in Smoldering Myeloma | Theresia Akhalghi, MD | ASH 2023Подробнее

ASH 2023 Multiple Myeloma Highlights – PERSEUS, IsKia, Bortezomib dosing, KarMMA-3Подробнее

IMWG Conference Series ASH 2023Подробнее

Genomic Profiling in High-Risk Smoldering Myeloma | Benjamin Diamond, MD | ASH 2023Подробнее

Management of High-Risk MyelomaПодробнее

Ultra high-risk MyelomaПодробнее

Updates in CLL - 2023 Best of Hematology ConferenceПодробнее

MDS - Myeloplastic Syndromes - 2023 Best of Hematology ConferenceПодробнее

February 10, 2023 | Post ASH CME Series 2022: Multiple MyelomaПодробнее

Update in Multiple MyelomaПодробнее

ASH 22 | Frailty and high risk patients updatesПодробнее

How to Better Diagnose Patients With High-Risk Myeloma | Martin Kaiser, MD | ASH 2022Подробнее

IMWG Conference Series: Reporting from ASH 2022Подробнее